Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

IBIO

iBio (IBIO)

iBio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:IBIO
DatumZeitQuelleÜberschriftSymbolFirma
05/06/202422h10Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
03/06/202422h08Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
03/06/202413h00GlobeNewswire Inc.iBio Closes Sale of Manufacturing Facility in TexasAMEX:IBIOiBio Inc
20/05/202412h55Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
13/05/202422h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
13/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
13/05/202422h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:IBIOiBio Inc
13/05/202422h08Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
13/05/202422h05GlobeNewswire Inc.iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate UpdateAMEX:IBIOiBio Inc
27/03/202412h00GlobeNewswire Inc.iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesAMEX:IBIOiBio Inc
27/03/202400h35GlobeNewswire Inc.iBio Announces $15.0 Million Private PlacementAMEX:IBIOiBio Inc
26/02/202413h59Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
26/02/202413h45GlobeNewswire Inc.iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaAMEX:IBIOiBio Inc
21/02/202422h55Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
19/01/202422h36Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
16/01/202414h15GlobeNewswire Inc.iBio Announces Participation in 23rd Annual PepTalk ConferenceAMEX:IBIOiBio Inc
10/01/202419h24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:IBIOiBio Inc
08/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
04/01/202414h00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:IBIOiBio Inc
26/12/202313h44Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
26/12/202313h15GlobeNewswire Inc.iBio Amends and Extends Maturity of Credit AgreementAMEX:IBIOiBio Inc
08/12/202322h17Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
06/12/202315h13Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
06/12/202314h59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:IBIOiBio Inc
05/12/202314h00GlobeNewswire Inc.iBio, Inc. Announces Pricing of $4.5 Million Public OfferingAMEX:IBIOiBio Inc
05/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:IBIOiBio Inc
30/11/202314h55Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:IBIOiBio Inc
28/11/202314h36Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
27/11/202323h20GlobeNewswire Inc.iBio Announces Reverse Stock SplitAMEX:IBIOiBio Inc
03/11/202321h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
 Showing the most relevant articles for your search:AMEX:IBIO